Grissinger Matthew, Rich Darryl
Institute for Safe Medication Practices, Huntingdon Valley, PA, USA.
J Am Pharm Assoc (Wash). 2002 Sep-Oct;42(5 Suppl 1):S54-5.
JCAHO standards have been revamped to focus on patient safety, and medications are an important area of emphasis. A proactive FMEA can identify a nd prevent potential problems in medication systems. Institutions should create or modify policies to require clear, unambiguous communication of medication orders. Patients and families should be taught to question procedures or medications that they do not think they should be receiving. Within a nonpunitive environment, staff should be educated about error-prone processes, high-risk patients, and high-alert medications.
医疗机构评审联合委员会（JCAHO）的标准已进行修订，以专注于患者安全，而药物是重点关注的一个重要领域。积极主动的失效模式与效应分析（FMEA）可以识别并预防药物系统中的潜在问题。各机构应制定或修改政策，要求对用药医嘱进行清晰、明确的沟通。应教导患者及其家属对他们认为不应接受的程序或药物提出疑问。在一个无惩罚的环境中，应让工作人员了解容易出错的流程、高危患者和高警示药物。
